Inhibition of Disruptor of Telomeric Silencing 1-Like Alleviated Renal Ischemia and Reperfusion Injury-Induced Fibrosis by Blocking PI3K/AKT-Mediated Oxidative Stress

References

• Kunzendorf U, Haase M, Rolver L, Haase-Fielitz A. Novel aspects of pharmacological therapies for acute renal failure. Drugs. 2010;70(9):1099–1114. doi:10.2165/11535890-000000000-0000020518578
   PubMed Web of Science ®Google Scholar
• Venkatachalam MA, Weinberg JM, Kriz W, Bidani AK. Failed tubule recovery, AKI-CKD transition, and kidney disease progression. J Am Soc Nephrol. 2015;26(8):1765–1776. doi:10.1681/ASN.201501000625810494
   PubMed Web of Science ®Google Scholar
• Xie Y, Xiao J, Fu C, Zhang Z, Ye Z, Zhang X. Ischemic preconditioning promotes autophagy and alleviates renal ischemia/reperfusion injury. Biomed Res Int. 2018;2018:8353987.29607326
   PubMed Web of Science ®Google Scholar
• Zhao H, Alam A, Soo AP, George A, Ma D. Ischemia-reperfusion injury reduces long term renal graft survival: mechanism and beyond. EBioMedicine. 2018;28:31–42.29398595
   PubMed Web of Science ®Google Scholar
• Javedan G, Shidfar F, Davoodi SH, et al. Conjugated linoleic acid rat pretreatment reduces renal damage in ischemia/reperfusion injury: unraveling antiapoptotic mechanisms and regulation of phosphorylated mammalian target of rapamycin. Mol Nutr Food Res. 2016;60(12):2665–2677. doi:10.1002/mnfr.20160011227466783
   PubMed Web of Science ®Google Scholar
• Peng Q, Wu W, Wu KY, et al. The C5a/C5aR1 axis promotes progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia/reperfusion injury. Kidney Int. 2019;96:117–128. doi:10.1016/j.kint.2019.01.03931029505
   PubMed Web of Science ®Google Scholar
• Min J, Feng Q, Li Z, Zhang Y, Xu RM. Structure of the catalytic domain of human DOT1L, a non-SET domain nucleosomal histone methyltransferase. Cell. 2003;112(5):711–723. doi:10.1016/S0092-8674(03)00114-412628190
   PubMed Web of Science ®Google Scholar
• Wong M, Tee A, Milazzo G, et al. The histone methyltransferase DOT1L promotes neuroblastoma by regulating gene transcription. Cancer Res. 2017;77(9):2522–2533. doi:10.1158/0008-5472.CAN-16-166328209620
   PubMed Web of Science ®Google Scholar
• McLean CM, Karemaker ID, van Leeuwen F. The emerging roles of DOT1L in leukemia and normal development. Leukemia. 2014;28(11):2131–2138. doi:10.1038/leu.2014.16924854991
   PubMed Web of Science ®Google Scholar
• Kim W, Kim R, Park G, Park JW, Kim JE. Deficiency of H3K79 histone methyltransferase Dot1-like protein (DOT1L) inhibits cell proliferation. J Biol Chem. 2012;287(8):5588–5599. doi:10.1074/jbc.M111.32813822190683
   PubMed Web of Science ®Google Scholar
• Oktyabri D, Ishimura A, Tange S, Terashima M, Suzuki T. DOT1L histone methyltransferase regulates the expression of BCAT1 and is involved in sphere formation and cell migration of breast cancer cell lines. Biochimie. 2016;123:20–31.26783998
   PubMed Web of Science ®Google Scholar
• Gao Y, Ge W. The histone methyltransferase DOT1L inhibits osteoclastogenesis and protects against osteoporosis. Cell Death Dis. 2018;9(2):33. doi:10.1038/s41419-017-0040-529348610
   PubMed Web of Science ®Google Scholar
• Castano BM, Cailotto F, Kerkhof HJ, et al. Genome-wide association and functional studies identify the DOT1L gene to be involved in cartilage thickness and hip osteoarthritis. Proc Natl Acad Sci U S A. 2012;109(21):8218–8223. doi:10.1073/pnas.111989910922566624
   PubMed Web of Science ®Google Scholar
• Chatterjee PK, Cuzzocrea S, Brown PA, et al. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int. 2000;58(2):658–673. doi:10.1046/j.1523-1755.2000.00212.x10916089
   PubMed Web of Science ®Google Scholar
• Noiri E, Nakao A, Uchida K, et al. Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol. 2001;281(5):F948–F957. doi:10.1152/ajprenal.2001.281.5.F94811592952
   PubMed Web of Science ®Google Scholar
• de Araujo M, Andrade L, Coimbra TM, Rodrigues AJ, Seguro AC. Magnesium supplementation combined with N-acetylcysteine protects against postischemic acute renal failure. J Am Soc Nephrol. 2005;16(11):3339–3349. doi:10.1681/ASN.200410083216177005
   PubMed Web of Science ®Google Scholar
• Zhang YL, Zhang J, Cui LY, Yang S. Autophagy activation attenuates renal ischemia-reperfusion injury in rats. Exp Biol Med (Maywood). 2015;240(12):1590–1598. doi:10.1177/153537021558130625898836
   PubMed Web of Science ®Google Scholar
• Yuan XP, Liu LS, Chen CB, et al. MicroRNA-423-5p facilitates hypoxia/reoxygenation-induced apoptosis in renal proximal tubular epithelial cells by targeting GSTM1 via endoplasmic reticulum stress. Oncotarget. 2017;8(47):82064–82077. doi:10.18632/oncotarget.1828929137244
   PubMedGoogle Scholar
• Tong X, Khandelwal AR, Qin Z, et al. Role of smooth muscle Nox4-based NADPH oxidase in neointimal hyperplasia. J Mol Cell Cardiol. 2015;89(Pt B):185–194. doi:10.1016/j.yjmcc.2015.11.01326582463
   PubMed Web of Science ®Google Scholar
• Babelova A, Avaniadi D, Jung O, et al. Role of Nox4 in murine models of kidney disease. Free Radic Biol Med. 2012;53(4):842–853. doi:10.1016/j.freeradbiomed.2012.06.02722749956
   PubMed Web of Science ®Google Scholar
• Pefanis A, Ierino FL, Murphy JM, Cowan PJ. Regulated necrosis in kidney ischemia-reperfusion injury. Kidney Int. 2019;96:291–301. doi:10.1016/j.kint.2019.02.00931005270
   PubMed Web of Science ®Google Scholar
• Chen X, Liu X, Wan X, Wu Y, Chen Y, Cao C. Ischemic preconditioning attenuates renal ischemia-reperfusion injury by inhibiting activation of IKKbeta and inflammatory response. Am J Nephrol. 2009;30(3):287–294. doi:10.1159/00022592819546526
   PubMed Web of Science ®Google Scholar
• Tanaka T. A mechanistic link between renal ischemia and fibrosis. Med Mol Morphol. 2017;50(1):1–8. doi:10.1007/s00795-016-0146-327438710
   PubMed Web of Science ®Google Scholar
• Wang L, Chen H, Liu XH, et al. Ozone oxidative preconditioning inhibits renal fibrosis induced by ischemia and reperfusion injury in rats. Exp Ther Med. 2014;8(6):1764–1768. doi:10.3892/etm.2014.200425371729
   PubMed Web of Science ®Google Scholar
• De Vos D, Frederiks F, Terweij M, et al. Progressive methylation of ageing histones by Dot1 functions as a timer. EMBO Rep. 2011;12(9):956–962. doi:10.1038/embor.2011.13121760613
   PubMed Web of Science ®Google Scholar
• Vlaming H, van Leeuwen F. The upstreams and downstreams of H3K79 methylation by DOT1L. Chromosoma. 2016;125(4):593–605. doi:10.1007/s00412-015-0570-526728620
   PubMed Web of Science ®Google Scholar
• Onder TT, Kara N, Cherry A, et al. Chromatin-modifying enzymes as modulators of reprogramming. Nature. 2012;483(7391):598–602. doi:10.1038/nature1095322388813
   PubMed Web of Science ®Google Scholar
• Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol. 2011;7(12):684–696. doi:10.1038/nrneph.2011.14922009250
   PubMed Web of Science ®Google Scholar
• Richter K, Konzack A, Pihlajaniemi T, Heljasvaara R, Kietzmann T. Redox-fibrosis: impact of TGFbeta1 on ROS generators, mediators and functional consequences. Redox Biol. 2015;6:344–352.26335400
   PubMed Web of Science ®Google Scholar
• Qin T, Yin S, Yang J, et al. Sinomenine attenuates renal fibrosis through Nrf2-mediated inhibition of oxidative stress and TGFbeta signaling. Toxicol Appl Pharmacol. 2016;304:1–8.27211841
   PubMed Web of Science ®Google Scholar